Catalyst Pharmaceuticals, Inc.

NASDAQ:CPRX

19.6 (USD) • At close September 6, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
Revenue 398.204214.203140.833119.073102.3060.500000000.48900000000
Cost of Revenue 84.53234.39321.88417.03914.75919.9190.0460.0430.0340000000000000
Gross Profit 313.672179.81118.949102.03487.547-19.419-0.046-0.043-0.03400000.48900000000
Gross Profit Ratio 0.7880.8390.8450.8570.856-38.8380000000100000000
Reseach & Development Expenses 93.1519.78916.93616.49718.84319.91911.37511.3711.80110.1188.0972.663.3842.3075.0978.712.9910.9891.4630.37800.138
General & Administrative Expenses 47.02128.71423.47720.66733.58115.8767.3047.918.5974.4742.2152.5622.6982.2062.1782.184000000
Selling & Marketing Expenses 86.68929.46926.15123.5673.300000000000000000
SG&A 133.7158.18349.62844.23436.88115.8767.3047.918.5974.4742.2152.5622.6982.2062.1782.1842.0361.9130.3590.16500
Other Expenses 7.6992.8810.2820.5871.5861.2920.4540.3220.10.0760000000000-0.4290.118
Operating Expenses 226.8677.97266.56460.7355.72435.79518.6819.2820.39814.59110.3125.2216.0824.5137.27510.8945.0272.9021.8220.543-0.4290.256
Operating Income 86.812101.83852.38541.30331.823-35.295-18.68-19.28-20.398-14.591-10.312-5.221-6.082-4.024-7.275-10.894-5.027-2.902-1.822-0.543-0.429-0.256
Operating Income Ratio 0.2180.4750.3720.3470.311-70.590000000-8.2300000000
Total Other Income Expenses Net 7.6992.8810.2820.5871.5861.2920.2671.2080.165-0.918-1.891.13-0.320.0180.0330.3290.8880.1730.0170.00300
Income Before Tax 94.511104.71952.66741.8933.409-34.004-18.412-18.072-20.233-15.509-12.155-4.076-6.391-4.006-7.242-10.565-4.139-2.729-1.805-0.540-0.256
Income Before Tax Ratio 0.2370.4890.3740.3520.327-68.0070000000-8.19400000000
Income Tax Expense 23.10121.6413.185-33.0931.5342.5830.141-0.93-0.0990.9941.843-1.1560.30900000000.4290
Net Income 71.4183.07939.48274.98331.875-34.004-18.412-18.072-20.233-15.509-12.155-4.076-6.391-4.006-7.242-10.565-4.139-2.729-1.805-0.54-0.429-0.256
Net Income Ratio 0.1790.3880.280.630.312-68.0070000000-8.19400000000
EPS 0.670.80.380.720.31-0.33-0.21-0.22-0.25-0.24-0.27-0.14-0.29-0.22-0.48-0.81-0.33-0.36-0.29-0.18-0.15-0.11
EPS Diluted 0.630.750.370.710.3-0.33-0.21-0.22-0.25-0.24-0.27-0.14-0.29-0.22-0.48-0.81-0.33-0.36-0.29-0.18-0.15-0.11
EBITDA 119.955101.83852.38541.30331.823-35.295-18.493-20.166-20.463-13.571-8.399-6.351-5.719-3.998-7.245-10.861-5.011-2.897-1.821-0.543-0.429-0.256
EBITDA Ratio 0.3010.4750.3720.3470.311-70.590000000-8.17700000000